CSRxP: Eli Lilly’s Zepbound Announcement Leaves Prices High for Most Patients, Serves as Powerful Reminder Big Pharma Alone Sets Prices
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Lowering Prices for Some Patients at Some Dosages Will Have Limited Impact,… Read More
Price Hikes and Egregious Prices on Blockbuster Drugs Boost Profits… Read More
Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies”… Read More
Big Pharma Continues Raking in Expectation-Beating Profits and Revenue Fueled… Read More
Bipartisan, Market-Based Solution Would Help Crack Down on Anti-Competitive… Read More
More Brand Name Drug Makers Beat Wall Street Earnings After Hiking Prices This… Read More
Big Pharma Giants Top Wall Street Expectations After Hiking Prices on… Read More
Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate… Read More
Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma… Read More
Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics… Read More
Latest Data Finds List Prices of Prescription Drug Prices Have Increased… Read More
Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That… Read More